Results 101 to 110 of about 3,021 (181)

25 The association of a documented prescription of medication for opioid use disorder (MOUD) during pregnancy with maternal outcomes [PDF]

Ashley Hailer, Pauline Terebuh, Rong Xu, David C. Kaelber, Pamela B. Davis   +4 more
openalex   +1 more source

Effects of the Communities that Heal (CTH) intervention on perceived opioid-related community stigma in the HEALing Communities Study: results of a multi-site, community-level, cluster-randomized trialResearch in context

The Lancet Regional Health. Americas
Summary: Background: Community stigma against people with opioid use disorder (OUD) and intervention stigma (e.g., toward naloxone) exacerbate the opioid overdose crisis.
Alissa Davis, Hannah K. Knudsen, Daniel M. Walker, Deborah Chassler, Karsten Lunze, Philip M. Westgate, Emmanuel Oga, Sandra Rodriguez, Sylvia Tan, JaNae Holloway, Sharon L. Walsh, Carrie B. Oser, R. Craig Lefebvre, Laura C. Fanucchi, LaShawn Glasgow, Ann Scheck McAlearney, Hilary L. Surratt, Michael W. Konstan, Terry T.-K. Huang, Patricia LeBaron, Julie Nakayima, Michael D. Stein, Maria Rudorf, Monica Nouvong, Elizabeth N. Kinnard, Nabila El-Bassel, Jess Tilley, Aaron Macoubray, Caroline Savitzky, Amy Farmer, Donna Beers, Pamela Salsberry, Timothy R. Huerta   +32 more
doaj   +1 more source

Examining changes in pain interference via pandemic-induced isolation among patients receiving medication for opioid use disorder: a secondary data analysis

BMC Public Health
Background Early in the pandemic, the United States population experienced a sharp rise in the prevalence rates of opioid use, social isolation, and pain interference.
Tessa Frohe, Tim Janssen, Bryan R. Garner, Sara J. Becker   +3 more
doaj   +1 more source

“You’re Not Supposed to be on it Forever”: Medications to Treat Opioid Use Disorder (MOUD) Related Stigma Among Drug Treatment Providers and People who Use Opioids [PDF]

, 2022
Julia Dickson‐Gómez, Antoinette L. Spector, Margaret R. Weeks, Carol L. Galletly, Madelyn McDonald, Helena Danielle Green Montaque   +5 more
openalex   +1 more source

Lessons from the First Wave of COVID-19 for Improved Medications for Opioid Use Disorder (MOUD) Treatment: Benefits of Easier Access, Extended Take Homes, and New Delivery Modalities

, 2022
Suzan M. Walters, David C. Perlman, Honoria Guarino, Pedro Mateu‐Gelabert, David Frank   +4 more
openalex   +2 more sources

Impacts of the COVID-19 pandemic on enrollment in medications for opioid use disorder (MOUD) in Vancouver, Canada: An interrupted time series analysis

, 2023
M. Eugenia Socías, Jin Cheol Choi, Nadia Fairbairn, Cheyenne Johnson, Dean Wilson, Kora DeBeck, Rupinder Brar, Kanna Hayashi   +7 more
openalex   +1 more source

The role of micro-, meso-, and macro-level stigma on the uptake of medications for opioid use disorder (MOUD) among women in the criminal legal system [PDF]

Oluwaseyi Quadri, Emma Skogseth, Kristina Brant, Abenaa Jones   +3 more
openalex   +1 more source

Medication for Opioid Use Disorder and Perioperative Outcomes for Benign Hysterectomy. [PDF]

O G Open
Huang Y, Li AH, Hou JY, Mauro PM, Xu X, Li G, Bisaga A, Hershman DL, Martins SS, Wright JD.   +9 more
europepmc   +1 more source

Assessing the Safety, User Acceptability, Dissemination, and Reach of a Comprehensive Web-Based Resource on Medications for Opioid Use Disorder (MOUD Hub): Protocol for a Development and Usability Study

Melanie J. Nicholls, Alexandra Almeida, Justin Castello, David J. Grelotti, Bianca Daugherty, Donny Gann, Karen Lenyoun, Sharon Trillo‐Park, Annick Bórquez   +8 more
openalex   +1 more source

Retention on Buprenorphine for Opioid Use Disorder in Justice-Involved Individuals: A Retrospective Cohort Study. [PDF]

Behav Sci (Basel)
Yatsco A, Vega FR, Cohen AS, Cardenas-Turanzas M, Langabeer JR, Champagne-Langabeer T.   +5 more
europepmc   +1 more source